Quadrature Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
MCMU
Quadrature Capital's RXRX Position: Q2 2026 in Review
Quadrature Capital opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 987,798 shares worth $3.63M. The stake represents 0.03% of the portfolio and ranks #356 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in RXRX as recently as Q4 2025.
Quadrature Capital first reported a position in RXRX in Q2 2025 and has held it in 4 quarters since. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.
- Quadrature Capital held 987,798 shares of Recursion Pharmaceuticals worth $3.63M as of Q2 2026.
- Recursion Pharmaceuticals was a new Quadrature Capital position in Q2 2026.
- Recursion Pharmaceuticals made up 0.03% of Quadrature Capital's portfolio in Q2 2026, its #356 holding.
- Quadrature Capital first reported a position in Recursion Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
- 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.
Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.